Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;113(1):19-27.
doi: 10.32074/1591-951X-230.

Neuroendocrine neoplasms of the appendix, colon and rectum

Affiliations
Review

Neuroendocrine neoplasms of the appendix, colon and rectum

Marco Volante et al. Pathologica. 2021 Feb.

Abstract

Neuroendocrine neoplasms of the appendix, colon and rectum are classified according to the most recent WHO classification as neuroendocrine tumors (NET), neuroendocrine carcinomas (NEC) and mixed neuroendocrine-non neuroendocrine neoplasms (MiNENs). NECs and MiNENs are aggressive neoplasms requiring multimodal treatment strategies. By contrast, NETs are, in most cases, indolent lesions occurring as incidental findings in the appendix or as polyps in the rectum. While most appendiceal and rectal NETs are considered relatively non-aggressive neoplasms, a few cases, may show a more aggressive clinical course. Unfortunately, clinical/pathological characteristics to select patients at high risk of recurrence/metastases are poorly consolidated. Diagnosis is generally easy and supported by the combination of morphology and immunohistochemistry. Differential diagnostic problems are for NECs/MiNENs with poorly differentiated adenocarcinomas, when immunohistochemical neuroendocrine markers are not obviously positive, whereas for NETs they are represented by the rare appendiceal tubular and clear cell variants (which may be confused with non-neuroendocrine cancers) and rectal L-cell tumors which may be chromogranin negative and prostatic marker positive.

Keywords: appendix; colon; neuroendocrine; rectum; tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The Authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Neuroendocrine tumor of the appendix associated with acute appendicitis (a), with invasion of the mesoappendix (b), infiltrative growth, highlighted by chromogranin A immunohistochemical staining (c), but with low mitotic and proliferative index (Ki-67 staining) coding for G1 tumor grade (d).
Figure 2.
Figure 2.
Neuroendocrine tumor of the appendix, clear cell variant, with clear granular cells (a) negative for PAS staining (b) and with diffuse granular positivity for chromogranin A (c) and nuclear positivity for CDX-2 (d).
Figure 3.
Figure 3.
Poorly differentiated neuroendocrine carcinoma of the colon (a). Mixed neuroendocrine-non neuroendocrine neoplasm (MiNEN) (b) with poorly differentiated neuroendocrine component (yellow asterisk) and adenomatous component (green asterisk). Mixed neuroendocrine-non neuroendocrine neoplasm (MiNEN) with poorly differentiated neuroendocrine component (yellow asterisk) and adenocarcinoma with evident mucin production (black asterisk) (c). Synatophysin of MiNEN (d) showing diffuse expression in the neuroendocrine component (yellow asterisk) and no expression in the adenocarcinomatous areas (black asterisk).
Figure 4.
Figure 4.
Rectal well differentiated neuroendocrine tumor L-cell type (a). Ribbon-like and festooned architecture of cytologically bland cells (b). L-cell rectal NET with pseudo-glandular architecture and overlying mucosa (c). Lympho-vascular invasion is an important prognostic factor (d).

References

    1. WHO Classification of Tumors Editorial Board. Digestive system tumors. WHO Classification of Tumors. 5th ed. Lyon: IARC press; 2019.
    1. Njere I, Smith LL, Thurairasa D, et al. . Systematic review and meta-analysis of appendiceal carcinoid tumors in children. Pediatr Blood Cancer 2018;65:e27069. https://doi.org/10.1002/pbc.27069 10.1002/pbc.27069 - DOI - PubMed
    1. Onyemkpa C, Davis A, McLeod M, et al. . Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile and predictors. J Gastrointest Oncol 2019;10:300-6. https://doi.org/10.21037/jgo.2018.11.08 10.21037/jgo.2018.11.08 - DOI - PMC - PubMed
    1. Rault-Petit B, Do Cao C, Guyétant S, et al. . Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a national study from the French Group of Endocrine Tumors (GTE). Ann Surg 2019;270:165-71. https://doi.org/10.1097/SLA.0000000000002736 10.1097/SLA.0000000000002736 - DOI - PubMed
    1. La Rosa S, Finzi G, Puppa G, et al. . Lipid-rich variant of appendiceal well-differentiated endocrine tumor (carcinoid). Am J Clin Pathol 2010;133:809-14. https://doi.org/10.1309/AJCP0NWA1DBDZIOY 10.1309/AJCP0NWA1DBDZIOY - DOI - PubMed

LinkOut - more resources